Early dose reduction of dasatinib does not compromise clinical outcomes in patients with chronic myeloid leukemia: A comparative analysis of two prospective trials

Autor: Shin, Dong-Yeop, Park, Sahee, Jang, Eunjung, Kong, Jee Hyun, Won, Young-Woong, Oh, Sukjoong, Choi, Yunsuk, Kim, Jeong-A, Lee, Se Won, Mun, Yeung-Chul, Kim, Hawk, Kim, Sung-Hyun, Rok Do, Young, Kwak, Jae-Yong, Kim, Hyeoung-Joon, Zang, Dae Young, Lim, Sung-Nam, Lee, Won Sik, Kim, Dong-Wook
Zdroj: In Leukemia Research August 2024 143
Databáze: ScienceDirect
Externí odkaz: